Live feed
Filing
SC 13D/A
SC 13D/A0001564590-22-026039·Griffiths Richard Ian
Schedule 13D ownership disclosure
Silence Therapeutics plc
Security class unavailable · CUSIP: G8128Y157
Event date: 2022-07-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 25,469,271
- Percent of class
- 28.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001564590-22-026039
- Form type
- SC 13D/A
- Filer
- Griffiths Richard Ian
- CIK
- CIK 1846370
- Filed
- Jul 20, 2022
- Reporting period
- Jul 19, 2022
- Description
- Schedule 13D beneficial ownership